This information was published on 2026-05-12T00:14:19 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2627044 (IR 1160406) |
| (220) |
11 Dec 2025
|
| (511) (510) |
Class 5
Pharmaceutical preparations containing antibodies against botulinum toxin and therapeutic preparations for treating botulinum toxicity. |
| (540) | BAT |
| (550) | Word |
| (730) |
Emergent BioSolutions Canada Inc.
|
Find out more about publications on the About page.